Company intelligence / Profile preview

MC10

Lexington, Massachusetts, United Statesmc10.com.au ↗

Ownership: Private
Development stage: Commercial

Overview

MC10 developed the BioStamp nPoint system—a wearable sensor platform that collects physiological data in both home and clinical settings. The technology has been integrated into Medidata’s digital health offerings following acquisition. No drug or therapeutic trial results; focus is on enabling remote biometric data capture for research and therapy development.

Therapeutic areas: PulmonologyNeurologyOther
Modalities: Device (wearable biosensors)Digital health platform
Industry: Physiological Monitoring

Partnerships

Integrated with Medidata’s digital clinical trial platforms after acquisition by Medidata/Dassault Systèmes

Beyond the preview

Go deeper on MC10.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MC10.

Explore the full profile